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Abstract :  This study examines the consequences on  
cerebral polyamine biosynthesis of increases and de- 
creases in cerebral methylation. Increases were elicited 
by administering the convulsant agent methionine sul- 
foximine (MSO) and decreases by elevating in vivo the 
cerebral levels of the methylation inhibitor S-adenosyl- 
homocysteine. Following the intraventricular (i.vt.) ad- 
ministration of one of the two possible polyamine pre- 
cursors, [ 1 ,4-14C]putrescine, the specific radioactivity 
(sra) of the newly formed [14C]spermidine remained un- 
changed. Conversely, after i.vt. ~-[3,4-’~C]methionine, 
the other polyamine precursor, significantly higher sra 
values for [ I4C]spermidine and [ 14C]spermine were re- 
corded in the brains of the MSO-treated animals. [I4C]S- 
adenosylmethionine in the brain of the MSO-treated ani- 
mals was also more highly labeled following [1-14C]- 
methionine, indicating its accelerated formation relative 
to controls. We also investigated the effect of the admin- 
istration of adenosine + hornocysteine, a treatment that 
results in elevated brain adenosylhomocysteine levels, on 
polyamine biosynthesis from [3,4-14C]-methionine. The 
results of these experiments show both significantly lower 
sra values for [ 14C]spermidine and [14C]spermine and sig- 
nificantly higher than control endogenous methionine 
levels, a clear sign of the existence of a retardation in the 
conversion of methionine to polyamines under these con- 
ditions. In conclusion, the present study demonstrates 
that while interference with cerebral methylation results 
in significant alterations of the rate of formation of the 
methionine moiety of spermidine and spermine, it has no 
effect on the entry of the putrescine moiety into the two 
polyamine molecules .  K e y  Words: Polyamines- 
Biosynthesis-Methionine sulfoximine4-adenosylhomo- 
cysteine. Porta R. et al. The biosynthesis of polyamines 
in mouse brain: Effects of methionine sulfoximine and 
adenosylhomocysteine. J .  Neurochem. 40, 836-841 
(1983). 
Previous research has demonstrated that the ad- 
ministration of the convulsant agent L-methionine- 
dl-sulfoximine (MSO) results in an accelerated 
transfer of S-adenosyl-L-methionine (AdoMet)- 
derived methyl groups to a number of cerebral 
methyl acceptor molecules, which, to date, include 
histamine, transfer ribonucleic acids, proteins, and 
phospholipids (Schatz and Sellinger, 197%; Salas et 
al., 1977; Schatz et al., 1978; 1982a,h,; Dainat et al., 
1978; Sellinger and Schatz, 1979). Unexpectedly, 
the levels of the resulting S-adenosyl-L-homocys- 
teine (AdoHcy), a potent inhibitor of all methyla- 
tions, were not found to be correspondingly ele- 
vated, but rather somewhat decreased (Schatz et 
al., 1977; 1982u,b), possibly because of the con- 
tinued, effective AdoHcy-removal action of cere- 
bral AdoHcy hydrolase (Schatz et al., 1979), despite 
its moderate inhibition by MSO (Schatz et al., 
1977). 
In conjunction with our interest in understanding 
the mechanism whereby MSO “stimulates,” albeit 
indirectly, cerebral methylations (Sellinger and 
Schatz, 1979), we recently investigated means of 
counteracting the effects of this convulsant agent by 
retarding cerebral methylations. An effective way 
to do this was found to be the administration of 
adenosine and homocysteine thiolactone, jointly 
and upwards of a dose of 200 mglkg of each sub- 
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stance. As clearly shown by Schatz et al. (1981a), at 
a dose of 500 mg/kg this treatment causes a seven- 
fold elevation of cerebral AdoHcy levels, a condi- 
tion that effectively annihilates any MSO-elicited 
stimulation of the methyl transfer reactions enu- 
merated above (Schatz et  al., 1982b). Thus, two dif- 
ferent ways of modulating cerebral methylations 
have become available, an upward modulation in 
response to MSO and a downward one in response 
to AdoHcy. 
In addition to being the universal methyl donor 
molecule, AdoMet is also a precursor of the cere- 
bral polyamines spermidine and spermine via its de- 
carboxylation and the subsequent coupling of the 
n-propylamino moiety of decarboxylated AdoMet 
with putrescine and spermidine. Since polyamines 
have been found to possess excitatory properties 
when introduced directly into the brain of rodents 
(Anderson et al., 1975), and since a relationship be- 
tween audiogenic seizure sensitivity and brain poly- 
amines has recently been established in deermice 
(Porta et al., 1981u), it became of interest to investi- 
gate the possibility that treatments that affect cere- 
bral methylations, and hence the utilization and 
disposition of AdoMet, also disrupt the synthetic 
mechanisms leading to spermidine and spermine. We 
decided, therefore, to examine the effects of MSO and 
of high brain AdoHcy levels on the respective in- 
corporation of putrescine and methionine into cere- 
bral spermidine and spermine. A partial account of 
some of the findings has already appeared (Porta 
et al., 1981h; 1982). 
MATERIALS AND METHODS 
A model 204 liquid chromatograph with models 440 uv 
absorbance detector (254 nm), 6000A solvent delivery 
system, and U6K universal injector (all from Waters As- 
sociates Inc., Milford, MA) was used for high perfor- 
mance liquid chromatography (HPLC) analyses. The 
photometer output was displayed on an Omniscribe strip 
chart recorder (Texas Instruments, Austin, TX). The col- 
umn used for reverse-phase HPLC was pBondapak C,, (4 
mm i.d. x 30 cm) (Waters Associates). 
[ 1 ,4-L4C]Putrescine dihydrochloride (122 mCi/mmol), 
[ I4C]spermidine t r ihydrochlor ide  (122 mCiimmol), 
[ ''C]spermine tetrahydrochloride (122 mCi/mmol), and 
L-[ l-14C]methionine (59 mCi/mmol) were obtained from 
Amersham-Sear le  (Arl ington Heights ,  IL);  ~ - [ 3 , 4 -  
'Tlmethionine (49 mCiimmol) from Research Products 
International Corp. (Elk Grove Village, IL); [14C]ad- 
enosylmethionine (57 mCiimmol) from New England 
Nuclear (Boston); putrescine dihydrochloride, sper- 
midine trihydrochloride, spermine tetrahydrochloride, 
L-methionine-d,l-sulfoximine, adenosine, and D,I--ho- 
mocysteine thiolactone-HCI from Sigma Chemical Co. 
(St. Louis). S- Adenosylmethionine disulfate d i p  toluene- 
sulfonate was generously donated by Dr. G. Strament- 
inoli (BioResearch Laboratories, Liscate, Italy). Dowex 
50 W-X8 (200-400 mesh) was from BioRad (Richmond, 
CA). All other reagents were analytical grade. 
Adult male Swiss-Webster mice (25-30 g) were from 
Charles River Laboratories (Portage, MI) and were 
housed (7:OO a.m. to 7:OO p.m. light cycle followed by a 
12-h dark cycle) in stainless steel cages (six mice/cage) for 
a t  least 48 h before use. The mice were fasted overnight 
but were allowed water ud libitum prior to the experi- 
mental procedures. After treatment each animal was 
transferred to an individual cage. 
Injection schedules a n d  routes 
of administration 
All injections were carried out between 8:OO and 11:OO 
a.m. MSO was given intraperitoneally (i.p.) at a dose of 
150 mg/kg in saline (10 mVkg). The mixture of adenosine + 
homocysteine thiolactone (dissolved in salineiTween 80, 
20 mlikg) was injected i.p. a t  doses of 200 or 500 mg/kg, 
40 min prior to death. [ 1,4-'T]Putrescine (0.25 pCi/mouse), 
~-[3,4-~~C]methionine (1 or 2 pciimouse), and L-[~- I~C]-  
methionine (2 pCi/mouse) were injected into the lateral 
cerebral ventricle in a volume of 10 p l  of artificial cere- 
brospinal fluid (Merlis solution) (Schatz et al., 1978). For 
intraventricular (i.vt.) injections the animals were lightly 
anesthetized with ether and a small piece of scalp was re- 
moved for ease in identification of the injection site. They 
were killed by immersion (head first) into liquid nitrogen 
and were stored frozen overnight a t  -20°C. Whole brains 
were rapidly removed, immediately refrozen in liquid 
nitrogen, and kept at -20°C until the time of assay. 
Determination of the levels and specific 
radioactivities of methionine, 
S-adenosylmethionine, and  polyamines 
The quantitative determinations, using HPLC proce- 
dures, of tissue polyamine and AdoMet levels were car- 
ried out as previously described (Porta et al., 1981~) .  In 
experiments in which [ l,4-l4C]-putrescine, ~ - [ 3 , 4 - ' ~ C ] -  
methionine, o r  L-[ l-L4C]-methionine was injected, we de- 
termined the amounts of radioactivity in the newly pro- 
duced [ 14C]polyamines or  in [ 14C]AdoMet by collecting 
1 .O-ml fractions from the chromatographic runs. After 
addition of 6 ml of ACS (a tissue solubilizer-scintillation 
mixture, Amersham-Searle, Arlington Heights, IL), the 
fractions were counted and their radioactivity was used to 
calculate the specific radioactivity (sra, dpmhmol) val- 
ues. Tissue L-methionine levels were determined by the 
procedure of Parrilla e t  al. (1973), with some modifica- 
tions (Porta et al., 1981~) .  The determination of the cere- 
bral methionine sra, following L-[ 1- 14C]methionine i.vt. 
injections, was performed as previously described (Porta 
et al., 1981~). 
Statistical analysis 
two-tailed I-test at a 0.05 level of significance. 
The statistical significance was evaluated by Student's 
RESULTS 
Biosynthesis of brain polyamines in 
MSO-treated mice 
The determination of the steady state levels of 
brain polyamines was performed 30, 90, 135, and 
180 min after administration of MSO. A significant 
increase (-40%) of spermidine and spermine levels 
was observed only at  180 min, a time when the con- 
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vulsant action of MSO can no longer be effectively 
reversed (Sellinger et al., 1968). The levels of brain 
putrescine remained unchanged throughout the 3-h 
post-MSO period. 
Since in order for the methionine carbon to enter 
the spermidine moiety the injected methionine must 
first mix with the endogenous pool of methionine 
and then react with ATP and ATP:methionine 
adenosyltransferase to form the polyamine precur- 
sor AdoMet, it was important to determine the 
levels of brain methionine and AdoMet 3 h after 
MSO administration. The sra values of [14C]methi- 
onine and [14C]AdoMet were also determined. Ta- 
ble 1 shows significantly lower methionine and 
AdoMet contents in the MSO-treated brains. Con- 
versely, while the sra values of [ 14C]methionine 
were significantly higher than control at both pulse 
times, those of [ 14C]AdoMet appeared higher on- 
ly at 1 h. 
To analyze the precursor flux into spermidine and 
spermine in the MSO-treated animals, ~ - [ 3 , 4 -  
i4C]methionine or [ 1,4- 14C]putrescine was injected 
i.vt. in separate experiments and the animals killed 
1 or 3 h later. As shown in Table 2, the sra values of 
[ 14C]spermidine and [14C]spermine following methi- 
onine were significantly higher at 1, but not at 3 h. 
Following [14C]putrescine, on the other hand, there 
was no difference between the [14C]spermidine sra 
values of the MSO-treated and the control animals 
at either 1 or 3 h. Moreover, the [‘4C]spermine frac- 
tion never had any radioactivity (Table 3). 
Formation of [ 14C]spermidine and [ 14C]spermine 
after in vivo elevation of brain AdoHcy levels 
It was previously reported (Schatz et al., 1981~)  
that the coadministration of adenosine and 
homocysteine thiolactone results in an elevation of 
brain AdoHcy levels. Since such high levels of brain 
AdoHcy cause cerebral methylation to be inhibited 
(Schatz et al., 1981a,b), it was quite reasonable that 
the effects of such a state on polyamine biosyn- 
thesis be investigated. The results (Table 4) show a 
significant reduction relative to controls of the sra 
values of [ 14C]spermidine and [ 14C]spermine formed 
in 1 h after an i.vt. pulse of [3,4-I4C]methionine. In 
contrast to the results after MSO (Table 3),  the 
levels of brain methionine became significantly ele- 
vated (55%) after 500 mg/kg of adenosine + 
homocysteine thiolactone, whereas, in confirmation 
of our previous results (Schatz et al., 1981a,b), the 
levels of brain AdoMet failed to change. 
DISCUSSION 
In the neurochemical literature there is little 
information specifically concerning the formation 
of polyamines following the separate administra- 
tion of labeled methionine versus putrescine. An- 
trup and Seiler (1980) described long-term experi- 
ments designed to determine the turnover rates of 
polyamines following repeated daily i.p. doses of 
[ 14C]methionine and [ 14C]putrescine. These workers 
calculated apparent biological half-lives (t of 
13- 16 days for spermidine and of 18 days for sper- 
mine following methionine, whereas after putres- 
cine these fl,* values became much longer-42 days. 
Since this discrepancy in half-lives, as determined 
from the two precursors, held only for brain tis- 
sue, the authors concluded that this particular fea- 
ture ‘‘indicates an exceptional characteristic of 
polyamine metabolism in brain.” The turnover of 
polyamines in mouse brain, using [14C]putrescine 
administered i.vt., was also examined by Hietala et 
al. (1980), who determined the sra values for 
[14C]spermidine and [14C]spermine over a 60-h pe- 
riod, noting the attainment of maximum values at 
about 20 h. The decline in the sra values of [“CC]- 
putrescine itself following its i.vt. administration 
was determined as well and found to be extremely 
rapid (Pajunen et al., 1980), yielding a half-life of 
about 12 h. 
Given the demonstrated feasibility of utilizing 
i.vt.-administered precursors of the polyamines to 
effect the latter’s labeling in brain tissue, it ap- 
peared of interest to generate conditions that would 
differentially influence the disposition of putrescine 
and methionine into spermidine and spermine. This 
possibility seemed even more attractive given the 
TABLE 1. Effect of MSO on the endogenous levels and the specific radioactivities of mouse bruin 
[14C]methionine and [‘4C]S-adenosylmethionine 
[ 14C]Methionine [ 14C]S-Adenosylmethionine 
Pulse time 
(h) Control MSO % Change Control MSO % Change 
~ 
A 
1 0.85 C 0.08 (6) 1.86 t 0.23 (7)* +218 4.56 t 0.41 (6) 6.52 t 0.56 (7)“ + 43 
B* 144.8 t 10.1 (6) 111.4 t 8.7 (7)“ -23 22.9 t 1.91 (6) 12.4 t 1.20 (7)a -45.5 
3 0.14 & 0.02 (8) 0.28 t 0.02 ( S ) r  + 100 1.60 t 0.16 (8) 1.80 t 0.18 (8) +11.3 
~ 
Mice were given an i.p. injection of saline or MSO (150 mg/kg) 3 h before killing. ~-[l-~~C]methionine: 2 and 1 pCi/lO p1 were in- 
jected for the determination of the specific radioactivities of S-adenosylmethionine and methionine, respectively. Values are expressed 
as means % SEM. A: dpmhmol: B: nmol/g. Numbers in parentheses represent the number of animals in each group. 
a-r Significantly different from control value: a,  p < 0.02: b, p < 0.005; c, p < 0.001. 
Determined 3 h after MSO. 
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TABLE 2. Effect of M S O  on the conversion of [3,4-'*C]methionine 
to [14C]spermidine and [14C]spermine in mouse brain 
[ 14C] Spermidi ne [ I4C]Spermine 
Pulse time 
% Change (h) Control MSO % Change Control MSO 
I "  28.4 t 1.0 (7) 42.7 ? 3.9 (ll)a +50.0 40.1 ? 1.2 (7) 60.6 ? 4.3 ( l l )b  +50.4 
3" 22.4 k 1.6 (6) 25.4 -+ 0.08 (12) +11.5 38.8 2 2.4 (6) 40.6 ? 1 .1  (8) + 10.4 
~ 
Mice were given an i.p. injection of MSO (150 mg/kg) 3 h before killing. Numbers in parentheses represent the number of animals 
in each experimental group. Values are in dpdnmol. 
Significantly different from control value: p < 0.005. 
* Significantly different from control value: p < 0.001. 
2 pCi of [3,4-14C]methionine was injected. 
ci 1 pCi of [3,4-14C]methionine was injected. 
previously documented finding (Antrup and Seiler, 
1980) that "the two parts of the polyamine structure 
deriving from ornithine and methionine, respec- 
tively, can have widely different biological life 
spans." The experimental conditions chosen in the 
present study to create the desired circumstances 
were those apt to  change the state of cerebral 
methylation. These were established by accelerat- 
ing the rate of methyl transfer, i.e., administering 
methionine sulfoximine, and by creating an acute 
methylation-inhibitory state by the administration 
of adenosine + homocysteine thiolactone. 
The administration of MSO caused significant, 
but moderate, reductions in the endogenous levels 
of brain methionine and AdoMet, 23 and 45%, re- 
spectively (Table 1). Yet ,  the  s ra  values of 
[I4C]methionine in the MSO-treated brains were 
higher than control by as much as 218 and 100% at, 
respectively, 1 and 3 h after MSO. These results 
indicate a preferential effect of MSO on the entry 
and maintenance of exogenous ['4C]methionine in 
the cellular pool, as against its effect on the efflux or 
the rate of utilization of endogenous methionine. 
The effect of MSO at the level of brain AdoMet was 
somewhat different, since the size of the reduction 
of its endogenous content (as percentage), noted 
several times previously (Schatz et  al., 197%; 
1982a,b), was virtually equal to the percentage in- 
crease of its sra. Still, the MSO-stimulated flux of 
[14C]-methionine into the cellular pool containing 
[14C]AdoMet was readily reflected by the signifi- 
cantly increased sra values of [14C]spermidine and 
[ ''C]spermine in the brains of the MSO-treated mice 
(Table 2), relative to controls. This was particularly 
evident at  1 h. 
The data shown in Table 3 support the conclusion 
of Antrup and Seiler (1980) regarding differences in 
the rates of entry of methionine and putrescine into 
the spermidine and spermine structures, inasmuch 
as they emphasize the absence of an effect of a 
methylation-activating agent, MSO, on the moiety 
of the polyamines not derived from AdoMet. Thus, 
our findings strengthen the argument favoring en- 
tirely independent fluxes of putrescine and of 
AdoMet toward polyamines. Moreover, in partial 
accord with the findings of Hietala et al. (1980), we 
confirmed the fact that formation of spermine from 
putrescine is markedly slower-in our case nil 
(Table 3)-than that of spermidine. After about 5 h 
of i.vt. putrescine administration Hietala et  al. 
noted a spermine/spermidine ratio of about 0.2. 
Similarly, the threefold decline in the s ra  of 
[*4C]putrescine from 1 to 3 h (Table 3) is in accord 
with the data of Pajunen et al. (1980), who noted a 
similar, albeit somewhat slower, decline of the sra 
of [14C]putrescine during the first 5 h following its 
injection. 
The downward modulation of cerebral methyla- 
tion rates can be effectively achieved and main- 
tained by increasing brain levels of AdoHcy. Such 
an increase occurs within minutes of the i.p. ad- 
ministration of 200 mg/kg of adenosine and 
homocysteine thiolactone (Schatz et  al., 1981~) .  It 
has been shown conclusively that decreased trans- 
methylation rates are an immediate consequence of 
the resulting high AdoHcy brain levels (Schatz et 
TABLE 3. Efiect of MSO on the conversion of [I ,4-'4C]putrescine 
to [ ''C]spermidine in mouse brain 
[ 14C]Putrescine [ 14C] Spermidine 
Pulse time 
(h) Control MSO Control MSO 
1 64.7 ? 4.8 (6) 57.0 & 3.6 (6)a 547.5 ? 47.5 (6) 514.8 ? 48.5 (6) 
3 23.5 ? 1.7 ( 1 1 )  24.0 2 0.7 (15)" 507.0 -C 21.0 (10) 554.4 ? 25.0 (14) 
Mice were given an i.p. injection of MSO (150 mg/kg) 3 h before killing. Values are in dpdnmol and are ex- 
a p values were greater than 0.05. 
pressed as means ? SEM. Numbers in parentheses represent the number of animals in each group. 
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TABLE 4. Effect of udenosine + hornocysteine thiolactone on the conversion of 
~-[3,4-'~C]methionine to [14C]spermidine and ['4C]spermine in mouse brain 
Spermidine Spermine 
Treatmenta dpm/nmol % Changeh p' dpmlnmol %Change p' 
~ 
- - - 16.76 f 0.94 - Vehicle 12.32 t 0.69 
200 mg/kg 9.42 -+ 1.24 -23.5 NS 14.62 ? 1.73 - 12.8 NS 
500 mg/kg 8.84 ? 0.67 -28.2 <0.005 13.00 -+ 1.19 -22.4 c0.05 
NS: Not significant. 
Adenosine + homocysteine thiolactone were administered i.p. 40 rnin before killing; ~-[3,4-'*C]- 
methionine (1.0 KCi) was injected i.vt. 1 h before killing. Six animals were used in each group. Values 
are means t SEM. 
* Compared with vehicle-treated mice. 
Determined by Student's t-test (two-tailed). 
al., 1981a,b), since all methyl transfer reactions 
tested to date were found to be markedly decreased. 
These have included the formation of N- methyl- 
histamine from histamine (Schatz et al., 1981a), 
the carboxylmethylation of cerebral proteins (Schatz 
et al., 1981b), and the formation of cerebral phos- 
phatidyl-N,N-dimethylethanolamine and lecithin 
(Schatz et al., 1981b). In additional experiments, 
designed to test the existence of an obverse rela- 
tionship between the action of MSO and high brain 
AdoHcy levels, we have demonstrated that a time- 
ly  adenosine + homocysteine thiolactone treat- 
ment (Schatz et al., 1981~; 1982u,b,c) causes a 
reversal of all MSO-elicited stimulations of cerebral 
methylation. Thus, it was not unexpected to find a 
decreased rate of [ 3,4-I4C]methionine incorporation 
into the spermidine and spermine structures fol- 
lowing the administration of 200 mg/kg of adenosine 
and homocysteine thiolactone (Table 4). 
Taken together with the stimulatory effect of 
MSO on [I4C]spermidine synthesis from [14C]me- 
thionine (Table 2), the present findings clearly show 
that it is possible to modulate upward or down- 
ward the incorporation of methionine into the n- 
propylamino moiety of brain polyamines by suitable 
adjustments in the state of cerebral methylation. 
Similarly, in nonneural systems, in vivo altera- 
tions in polyamine concentrations regulate AdoMet- 
dependent transmethylation reactions (Mach et al., 
1982), whereas the administration of AdoMet leads 
to changes in polyamine levels (Ientile et al., 1981). 
A particularly interesting aspect of the present 
study was its possible relevance to the question of 
the mechanism of MSO seizures. We reasoned that, 
by virtue of the capacity of MSO to stimulate the 
formation of AdoMet (Schatz et al., 1982b), its utili- 
zation for purposes of methyl transfer reactions 
(Salas et al., 1977; Dainat et al., 1978; Schatz et al., 
197%; 1978; 1981~; 19826), and the overall rate at 
which [ I4C]methionine enters the polyamine struc- 
tures (this study), the drug should also cause eleva- 
tions in brain spermidine and spermine, compounds 
with known convulsant properties (Anderson et al., 
1975; Shaw, 1979; Seiler, 1981). The significantly 
increased brain levels of the two polyamines 3 h 
after MSO (see Results) seem to support the va- 
lidity of this notion. Furthermore, we also show 
a decreased conversion of [ 14C]methionine into 
[ 14C]spermidine and [ 14C]spermine when brain 
AdoHcy levels are elevated and when, as Schatz et 
al. ( 1 9 8 % ~ )  have shown, MSO seizures are effec- 
tively antagonized. 
Acknowledgment: This work was supported by a 
grant from the U.S. Public Health Service, NINCDS 
06294 (OZS). 
REFERENCES 
Anderson D. J . ,  Crossland J., and Shaw G. G. (1975) The actions 
of spermidine and spermine on the central nervous system. 
Neuropharmacology 14, 571-577. 
Antrup H. and Seiler N. (1980) On the turnover of polyarnines 
spermidine and spermine in mouse brain and other organs. 
Neurochem. Res. 5, 123-143. 
Dainat J., Salas C. E., and Sellinger 0. Z. (1978) Alterations of 
the specificity of brain tRNA methyltransferase and of the 
pattern of brain tRNA methylation in vivo by methionine 
sulfoximine. Biochem. Pharmacol. 27, 2655-2658. 
Hietala 0. A., Pajunen A. E. I., Lapinjoki S. P.,  and Piha R. S. 
(1980) Interconversion of polyamines in mouse brain. Acta 
Univ. Oulu. A97, [Biochem.] 29, 49-54. 
Ientile P., Macaione S. ,  deLuca G . ,  Rotiroti D., and Di Giorgio 
R. M. (1981) Effects of SAM on polyamine levels and on 
ODC and GAD activities in rat retina during early postnatal 
development. Bull. Mol. Biol. Med. 6, 81-92. 
Mach M., Kersten H. ,  and Kersten W. (1982) Regulation of 
tRNA methyltransferase activities by spermidine and pu- 
trescine. Biochem. J. 202, 153- 162. 
Pajunen A. E. I., Lapinjoki S. P., Hietala 0. A,,  and Piha R. S. 
(1980) Polyamine turnover in mouse brain. Acta Univ. Oulir. 
A97, [Biuchem.] 29, 39-47. 
Parrilla R., Ayuso-Parrilla M. S. ,  and Goodman M. N.  (1973) 
Determination of some L-amino acids in biological samples 
by aminoacylation of tRNA. Anal. Biochem. 54, 362-369. 
Porta R., Doyle R. L., Tatter S. B . ,  Wilens T. E., Schatz R. A.,  
and Sellinger 0. 2. (1981~)  The biosynthesis of polyamines 
in the brain of audiogenic seizure-susceptible and -resistant 
deermice. J .  Neurochem. 37, 723-729. 
Porta R., Schatz R. A,,  and Sellinger 0. 2. (1981b) The modula- 
tion of brain methylation affects brain polyamine biosyn- 
thesis. Trans. Am. Soc. Neurochem. 12, 150. 
Porta R., Schatz R. A,,  and Sellinger 0. Z. (1982) Alterations in 
J .  Nerrrochem., Vol. 40, N o .  3, 1983 
BIOS YNTHESIS OF POL YAMINES IN BRAIN 841 
methylation affect polyamine biosynthesis in mouse brain, 
in l h e  Biochemistry of SAdenosylmethionine and Related 
Compounds (Borchardt R. T., Usdin E., and Creveling 
C. R., eds), pp. 581-588. Macmillan, London. 
Salas C .  E., Ohlsson W. G . ,  and Sellinger 0. Z. (1977) The 
stimulation of cerebral N2-methyl and Ng-dimethyl guanine- 
specific tRNA methyltransferases by methionine sul- 
foximine: An in vivo study. Biochem. Biophys. Res.  Com- 
mun. 76, 1107-1115. 
Schatz R. A. and Sellinger 0. 2. (1975~) The elevation of cere- 
bral histamine-N- and catechol-0-methyltransferase ac- 
tivities by L-methionine-dl-sulfoximine. J . Neurochem. 25, 
Schatz R. A. and Sellinger 0. Z. (19756) Effect of methionine 
and methionine sulfoximine on rat brain S-adenosylmethi- 
onine levels. J .  Neurochem. 24, 63-66. 
Schatz R. A., Vunnam C .  R., and Sellinger, 0. Z. (1977) S- 
Adenosyl-L-homocysteine in brain: Regional concentra- 
tions, catabolism and the effects of methionine sulfoximine. 
Neurochem. Res.  2, 27-38. 
Schatz R. A,, Frye K., and Sellinger 0. Z. (1978) Increased in 
vivo methylation of [3H]-histamine in the methionine sul- 
foximine epileptogenic mouse brain. J .  Pharmacol. Exp. 
Ther. 207, 794-800. 
Schatz R. A., Vunnam C. R., and Sellinger 0. Z. (1979) S- 
Adenosyl-L-homocysteine hydrolase from rat brain: Purifi- 
cation and some properties, in Transmethylation (Usdin E., 
Borchardt R. T., and Creveling C., eds), pp. 143-153. 
ElseviedNorth Holland Press, New York. 
Schatz R. A,,  Wilens T. E., and Sellinger 0. Z. (1981a) De- 
creased transmethylation of biogenic amines after in vivo 
elevation of brain S-adenosylhomocysteine. J .  Neurochem. 
Schatz R. A., Wilens T. E., and Sellinger 0. Z. (19816) De- 
creased in vivo protein and phospholipid methylation after in 
73-78. 
36, 1739- 1748. 
vivo elevation of brain 3-adenosylhomocysteine. Biochem. 
Biophys. Res.  Commun. 98, 1097-1 107. 
Schatz R. A,, Wilens T. E., and Sellinger 0. Z. (1981~) The ele- 
vation of brain S-adenosylhomocysteine in vivo counteracts 
the MSO-induced increase in phospholipid and protein car- 
boxymethylation. Trans. A m .  Soc. Neurochem. 12, 151. 
Schatz R .  A., Wilens T. E., Tatter S. B., and Sellinger 0. Z. 
(198k) Hypermethylation in the MSO-epileptogenic brain: 
reversal by dilantin and phenobarbital, in The Biochemistry 
of SAdenosylmethionine and Related Compounds. (Bor- 
chardt R. T., Usdin E., and Creveling C., eds), pp. 675- 
679. Macmillan, London. 
Schatz R. A., Wilens T. E., Tatter S. B., and Sellinger 0. Z. 
(19826) The elevation of brain S-adenosylhomocysteine 
counteracts seizures and brain hypermethylation induced 
by methionine sulfoximine. Submitted for publication. 
Schatz R. A., Wilens T.  E., Tatter S. B., and Sellinger 0. Z. 
(1982~) Hypermethylation in the MSO-epileptogenic brain: 
Reversal by dilantin, phenobarbital or adenosine plus 
homocysteine. Toxicologist 2, 2. 
Seiler N. (1981) Polyamine metabolism and function in brain. 
Neurochem, Int. 3 ,  95- 110. 
Sellinger 0. Z. and Schatz R. A. (1979) Cerebral utilization of 
adenosylmethionine and adenosylhomocysteine: Effects of 
methionine sulfoximine, in Biochemical and Pharmacologi- 
cal roles of Adenosylmethionine and the Central Nervous 
System. (Zappia V.,  Usdin E., and Salvatore F., eds), pp. 
89- 103. Pergamon Press, Elmsford. 
Sellinger 0. Z . ,  Azcurra J.  M., and Ohlsson W. G. (1968) Methi- 
onine sulfoximine seizures. VIII. The dissociation of the 
convulsant and glutamine synthetase inhibitory effects. J .  
Pharmacol. Exp. Ther. 164, 212-222. 
Shaw G. G. (1979) The polyamines in the central nervous sys- 
tem. Biochem. Pharmacol. 28, 1-6. 
J .  Neurochem., Vol. 40, No.  3, 1983 
